tiprankstipranks
Avient (AVNT)
NYSE:AVNT

Avient (AVNT) AI Stock Analysis

Compare
263 Followers

Top Page

AVAvient
(NYSE:AVNT)
68Neutral
Avient's stock demonstrates robust financial health with solid growth and profitability. The earnings call revealed strengths in revenue growth and innovation, albeit with some challenges. Technical indicators suggest cautious optimism, while valuation remains moderate. Overall, Avient is well-positioned for stability and growth, though monitoring FX and cost challenges is advised.
Positive Factors
Financial Strategy
AVNT has plans to mitigate tariff exposure by sourcing the majority of raw materials from other countries.
Organic Growth
AVNT reported SEM sales increased 8% on an organic basis, thanks to growth in healthcare and composites for building & construction, wind energy, and defense applications.
Negative Factors
Foreign Exchange Impact
FX headwinds are expected to be a $15MM headwind to EBITDA for the year.

Avient (AVNT) vs. S&P 500 (SPY)

Avient Business Overview & Revenue Model

Company DescriptionAvient Corporation (AVNT) is a global provider of specialized and sustainable material solutions, primarily serving the plastics and polymer industries. The company operates in sectors including healthcare, packaging, consumer goods, and transportation, offering a broad range of products such as color and additive systems, specialty engineered materials, and thermoplastic resins. Avient is committed to innovation and sustainability, focusing on developing materials that improve performance while reducing environmental impact.
How the Company Makes MoneyAvient Corporation makes money through the manufacturing and sale of high-performance materials and solutions tailored to customer specifications across various industries. The company's primary revenue streams include sales of its color and additives products, specialty engineered materials, and distribution services. Avient benefits from its global reach, serving a diverse customer base that spans multiple sectors, which helps mitigate risks associated with reliance on a single market. Strategic partnerships and collaborations with industry leaders enable Avient to leverage cutting-edge technologies and enhance its product offerings, further driving revenue growth. Additionally, the company's focus on innovation and sustainability attracts customers seeking environmentally friendly solutions, contributing to its earnings.

Avient Financial Statement Overview

Summary
Avient's financial health is robust, with solid revenue growth, improved profit margins, and a stable balance sheet. The company demonstrates effective operational efficiency with improved EBIT and gross profit margins. While leverage is moderate, it is countered by a strong equity position. Cash flow generation is solid, though there is room for enhancing free cash flow. Overall, Avient is on a positive financial trajectory, with potential for further growth.
Income Statement
75
Positive
Avient demonstrates stable revenue growth with a 3.11% increase from 2023 to 2024, indicating a positive growth trajectory. The gross profit margin improved to 32.60%, reflecting effective cost management. The net profit margin of 5.23% shows profitability, though there's room for enhancement. The EBIT margin increased to 10.16%, showing operational efficiency. Overall, the income statement indicates a robust performance with potential for further profit margin improvements.
Balance Sheet
70
Positive
The company's debt-to-equity ratio of 0.89 reflects moderate leverage, which is manageable but should be monitored. Avient's return on equity improved to 7.27%, indicating efficient equity usage to generate profits. The equity ratio of 40.08% shows a strong equity base. While the balance sheet is stable, maintaining or improving equity levels could bolster financial strength.
Cash Flow
68
Positive
Operating cash flow improved, showing a 27.38% increase, highlighting better cash generation from operations. The free cash flow to net income ratio of 0.80 suggests a strong capacity to convert income into cash flow, though there is scope to enhance free cash flow growth. Overall, cash flow is solid but could benefit from further growth in free cash flow.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
3.24B3.14B3.40B4.82B3.24B
Gross Profit
1.06B902.70M882.70M1.10B784.30M
EBIT
329.30M221.50M183.60M381.20M189.30M
EBITDA
329.30M391.40M427.20M472.90M352.90M
Net Income Common Stockholders
169.50M75.70M83.10M230.80M131.60M
Balance SheetCash, Cash Equivalents and Short-Term Investments
544.50M545.80M641.10M601.20M649.50M
Total Assets
5.81B5.97B6.08B5.00B4.87B
Total Debt
2.07B2.14B2.24B1.93B1.95B
Net Debt
1.52B1.59B1.60B1.33B1.30B
Total Liabilities
3.48B3.63B3.73B3.21B3.17B
Stockholders Equity
2.33B2.32B2.33B1.77B1.68B
Cash FlowFree Cash Flow
134.90M82.20M292.90M133.20M157.90M
Operating Cash Flow
256.80M201.60M398.40M233.80M221.60M
Investing Cash Flow
-120.60M-94.20M-504.00M-150.20M-1.43B
Financing Cash Flow
-120.90M-201.70M166.40M-114.60M982.00M

Avient Technical Analysis

Technical Analysis Sentiment
Negative
Last Price41.80
Price Trends
50DMA
41.91
Negative
100DMA
45.47
Negative
200DMA
45.29
Negative
Market Momentum
MACD
-0.25
Positive
RSI
46.01
Neutral
STOCH
49.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVNT, the sentiment is Negative. The current price of 41.8 is below the 20-day moving average (MA) of 42.59, below the 50-day MA of 41.91, and below the 200-day MA of 45.29, indicating a bearish trend. The MACD of -0.25 indicates Positive momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 49.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVNT.

Avient Risk Analysis

Avient disclosed 13 risk factors in its most recent earnings report. Avient reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Avient Peers Comparison

Overall Rating
UnderperformOutperform
Sector (47)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
EMEMN
74
Outperform
$11.16B12.6316.11%3.36%1.91%2.94%
68
Neutral
$3.90B23.127.32%2.45%3.11%123.46%
PPPPG
65
Neutral
$26.18B19.3419.13%2.33%-4.59%11.09%
ASASH
57
Neutral
$2.81B21.030.18%2.72%-4.35%-115.63%
CCCC
53
Neutral
$2.09B24.4312.98%7.15%-4.05%
CECE
50
Neutral
$6.04B6.84-24.69%3.86%-6.03%-177.29%
47
Neutral
$2.64B-4.00-31.55%3.33%2.93%-29.90%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVNT
Avient
41.80
0.97
2.38%
ASH
Ashland
58.37
-36.31
-38.35%
CE
Celanese
55.32
-99.66
-64.31%
EMN
Eastman Chemical
98.79
10.12
11.41%
PPG
PPG Industries
115.48
-23.95
-17.18%
CC
Chemours Company
14.12
-10.67
-43.04%

Avient Earnings Call Summary

Earnings Call Date: Feb 13, 2025 | % Change Since: 0.14% | Next Earnings Date: Apr 24, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mix of achievements and challenges. Avient successfully delivered organic revenue growth and margin expansion, launched significant innovations, and maintained a strong safety record. However, the discontinuation of the ERP project and the negative impacts from currency fluctuations and variable compensation posed challenges. The new healthcare and defense innovations provide promising growth opportunities, but the significant ERP-related charges and FX headwinds weigh on the outlook.
Highlights
Organic Revenue Growth and Margin Expansion
Avient achieved 4% organic revenue growth for the full year 2024, with both business segments (CAI and SEM) experiencing growth and margin expansion. Adjusted EBITDA margins expanded by 20 basis points to 16.2%.
New Innovation in Dyneema Portfolio
Avient launched a third-generation technology of Dyneema, offering unmatched ballistic protection and thermal performance. This innovation is up to 45% lighter for law enforcement and introduces new applications for military personnel.
Record Safety Performance
2024 was a record year for safety at Avient, with the lowest injury incident rate in the company's history.
Dividend Increase
Avient increased its dividend by 5%, marking the 14th consecutive year of annual dividend growth.
Strong Healthcare Segment Performance
Healthcare applications saw double-digit growth in 2024, driven by new business in remote monitoring devices and continuous glucose monitoring devices.
Lowlights
ERP System Implementation Halted
Avient decided to cease work on the S/4HANA ERP system due to increased complexity, cost, and risk. This decision resulted in a noncash impairment charge of approximately $71 million.
Impact of Foreign Exchange
The strengthening U.S. dollar negatively affected fourth-quarter EBITDA by $2 million and EPS by $0.01. For 2025, there is a forecasted $0.12 EPS headwind due to FX.
Variable Compensation Impact
Variable compensation accruals negatively impacted fourth-quarter adjusted EBITDA by $10 million and EPS by $0.08.
Company Guidance
During Avient Corporation's 2024 fourth-quarter earnings call, the company highlighted several key financial metrics and strategic initiatives. Organic sales for the year increased by 4%, with the Color, Additives, and Inks (CAI) segment growing by 3% and the Specialty Engineered Materials (SEM) segment by 6%. Both segments also experienced adjusted EBITDA margin expansions, with CAI increasing by 90 basis points and SEM by 110 basis points. Overall adjusted EBITDA margins for the company expanded by 20 basis points to 16.2%, and adjusted EPS grew by 13%, factoring in foreign exchange impacts. Avient announced a 5% dividend increase, marking the 14th consecutive year of dividend growth. For 2025, the company projected adjusted EBITDA between $540 million and $570 million and adjusted EPS ranging from $2.70 to $2.94, anticipating an 11% growth excluding foreign exchange impacts. The call also emphasized Avient's new strategic focus on innovation and sustainability, including the launch of the Dyneema-HB330 and Dyneema-HB332 products for defense applications, which offer superior ballistic protection. Additionally, the company made a significant decision to halt the implementation of the S/4HANA ERP system, resulting in a noncash impairment charge of approximately $71 million, favoring alternative solutions to achieve similar benefits at lower costs.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.